Cite
HARVARD Citation
Mpakou, V. et al. (2021). Upregulated hypoxia inducible factor 1α signaling pathway in high risk myelodysplastic syndrome and acute myeloid leukemia patients is associated with better response to 5‐azacytidine—data from the Hellenic myelodysplastic syndrome study group. Hematological oncology. 39 (2), pp. 231-242. [Online].